zan , Ocak Z, zan F, Oktay EA, Toptaş O, Şahman H, Yikilgan İ, Oruoğlu H, Er K. Association of Toll-like receptors 2, 3 and 4 genes polymorphisms with periapical pathosis risk. Med Oral Patol Oral Cir Bucal. 2016 Jul 1;21 (4):e408-12.  

 

 

doi:10.4317/medoral.21081

http://dx.doi.org/doi:10.4317/medoral.21081

 

 

 

1. Menezes-Silva R, Khaliq S, Deeley K, Letra A, Vieira AR. Genetic susceptibility to periapical disease: Conditional contribution of mmp2 and mmp3 genes to the development of periapical lesions and healing response. Journal of endodontics. 2012;38:604-7.
http://dx.doi.org/10.1016/j.joen.2012.02.009

 

2. Morsani JM, Aminoshariae A, Han YW, Montagnese TA, Mickel A. Genetic predisposition to persistent apical periodontitis. Journal of endodontics. 2011;37:455-9.
http://dx.doi.org/10.1016/j.joen.2011.01.009

 

3. Desai SV, Love RM, Rich AM, Seymour GJ. Toll-like receptor 2 expression in refractory periapical lesions. International endodontic journal. 2011;44:907-16.
http://dx.doi.org/10.1111/j.1365-2591.2011.01893.x

 

4. Ly M, Abeles SR, Boehm TK, Robles-Sikisaka R, Naidu M, Santiago-Rodriguez T, et al. Altered oral viral ecology in association with periodontal disease. mBio. 2014;5:e01133-4.
http://dx.doi.org/10.1128/mBio.01133-14

 

5. Matsumoto M, Oshiumi H, Seya T. Antiviral responses induced by the tlr3 pathway. Reviews in medical virology. 2011;21:67-77.
http://dx.doi.org/10.1002/rmv.680

 

6. Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor symposia on quantitative biology. 1989;54:1-13.
http://dx.doi.org/10.1101/SQB.1989.054.01.003

 

7. Kaisho T, Akira S. Toll-like receptor function and signaling. The Journal of allergy and clinical immunology. 2006;117:979-87.
http://dx.doi.org/10.1016/j.jaci.2006.02.023

 

8. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annual review of immunology. 2003;21:335-76.
http://dx.doi.org/10.1146/annurev.immunol.21.120601.141126

 

9. Seong SY, Matzinger P. Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nature reviews Immunology. 2004;4:469-78.
http://dx.doi.org/10.1038/nri1372

 

10. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, et al. Novel signal transduction pathway utilized by extracellular hsp70: Role of toll-like receptor (tlr) 2 and tlr4. The Journal of biological chemistry. 2002;277:15028-34.
http://dx.doi.org/10.1074/jbc.M200497200

 

11. Sukkar MB, Xie S, Khorasani NM, Kon OM, Stanbridge R, Issa R, et al. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. The Journal of allergy and clinical immunology. 2006;118:641-8.
http://dx.doi.org/10.1016/j.jaci.2006.05.013

 

12. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic acids research. 1988;16:1215.
http://dx.doi.org/10.1093/nar/16.3.1215

 

13. Karaca NE, Gulez N, Aksu G, Azarsiz E, Kutukculer N. Does om-85 bv prophylaxis trigger autoimmunity in iga deficient children?. International immunopharmacology. 2011;11:1747-51.
http://dx.doi.org/10.1016/j.intimp.2011.06.009

 

14. Lorenz E, Hallman M, Marttila R, Haataja R, Schwartz DA. Association between the asp299gly polymorphisms in the toll-like receptor 4 and premature births in the finnish population. Pediatric research. 2002;52:373-6.
http://dx.doi.org/10.1203/00006450-200209000-00011

 

15. Kinane DF, Hart TC. Genes and gene polymorphisms associated with periodontal disease. Crit Rev Oral Biol Med. 2003;14:430-49.
http://dx.doi.org/10.1177/154411130301400605

 

16. Ng YL, Mann V, Rahbaran S, Lewsey J, Gulabivala K. Outcome of primary root canal treatment: systematic review of the literature - Part 2. Influence of clinical factors. Int Endod J. 2008;41:6-31.
http://dx.doi.org/10.1111/j.1365-2591.2008.01484.x

 

17. Nair PN. Pathogenesis of apical periodontitis and the causes of endodontic failures. Critical reviews in oral biology and medicine: an official publication of the. American Association of Oral Biologists. 2004;15:348-81.

 

18. Karaca N, Ozturk G, Gerceker BT, Turkmen M, Berdeli A. Tlr2 and tlr4 gene polymorphisms in turkish vitiligo patients. Journal of the European Academy of Dermatology and Venereology : JEADV. 2013;27:e85-90.
http://dx.doi.org/10.1111/j.1468-3083.2012.04514.x

 

19. Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, Klotz M, Werfel T, Herz U, et al. The toll-like receptor 2 r753q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. The Journal of allergy and clinical immunology. 2004;113:565-7.
http://dx.doi.org/10.1016/j.jaci.2003.12.583

 

20. Tian LM, Xie HF, Yang T, Hu YH, Li J, Wang WZ. Association study of tumor necrosis factor receptor type 2 m196r and toll-like receptor 2 arg753gln polymorphisms with acne vulgaris in a chinese han ethnic group. Dermatology. 2010;221:276-84.
http://dx.doi.org/10.1159/000319851

 

21. Horie Y, Meguro A, Ota M, Kitaichi N, Katsuyama Y, Takemoto Y, et al. Association of tlr4 polymorphisms with behcet's disease in a korean population. Rheumatology (Oxford). 2009;48:638-42.
http://dx.doi.org/10.1093/rheumatology/kep077

 

22. Hennessy EJ, Parker AE, O'Neill LA. Targeting toll-like receptors: Emerging therapeutics?. Nature reviews Drug discovery. 2010;9:293-307.
http://dx.doi.org/10.1038/nrd3203